Related Experiment Videos
Nitric oxide and gastric relaxation
1Department of Gastrointestinal Pharmacology, Janssen Research Foundation, Beerse, Belgium.
Digestive Diseases and Sciences
|December 1, 1994
Summary
Pentagastrin increases gastric volume by stimulating acid secretion, independent of nitric oxide. Intralipid causes gastric relaxation through a nitric oxide-dependent pathway.
Area of Science:
- Gastroenterology
- Physiology
Background:
- Gastric distension influences gastric compliance and accommodation.
- Pentagastrin and intralipid are known to affect gastric function.
Purpose of the Study:
- To investigate the mechanisms underlying gastric relaxation induced by pentagastrin and intralipid.
- To determine the role of nitric oxide (NO) in these processes.
Main Methods:
- Isobaric gastric distension in conscious dogs.
- Administration of pentagastrin and intralipid.
- Use of acid secretion inhibitors, histamine, L-nitroarginine (L-NNA), and L-arginine.
Main Results:
- Pentagastrin enhanced gastric volume increase, an effect abolished by acid secretion inhibitors and mimicked by histamine.
- Pentagastrin's effect on compliance was not affected by L-NNA.
- L-NNA reduced volume increases during distension.
- Intralipid induced gastric relaxation sensitive to L-NNA inhibition, partially reversed by L-arginine.
Conclusions:
- Pentagastrin induces gastric relaxation via a mechanism involving gastric secretion but not nitric oxide.
- Intraduodenal intralipid induces gastric relaxation via a nitric oxide-dependent mechanism.